Cargando…

Human RNA Modifications Disease Database (HRMDD): A web resource for the molecular and clinical landscape of RNA modifications in human diseases

Detalles Bibliográficos
Autores principales:	Wang, Jianjian, Li, Lifang, Zhou, Hanxiao, Li, Shuang, Tian, Liting, Wang, Xinyue, Li, Danyang, Yin, Yue, Ning, Shangwei, Wang, Lihua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Chongqing Medical University 2022
Materias:	Rapid Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10311044/ https://www.ncbi.nlm.nih.gov/pubmed/37397534 http://dx.doi.org/10.1016/j.gendis.2022.08.024

Ejemplares similares

The RNA modification landscape in human disease
por: Jonkhout, Nicky, et al.
Publicado: (2017)

LncPCD: a manually curated database of experimentally supported associations between lncRNA-mediated programmed cell death and diseases
por: He, Ni, et al.
Publicado: (2023)

Age-Related Modifications in Circulating IL-15 Levels in Humans
por: Gangemi, Sebastiano, et al.
Publicado: (2005)

Landscape of the complete RNA chemical modifications in the human 80S ribosome
por: Taoka, Masato, et al.
Publicado: (2018)

Identification of circulating immune landscape in ischemic stroke based on bioinformatics methods
por: Li, Danyang, et al.
Publicado: (2022)

RNA2Immune: A Database of Experimentally Supported Data Linking Non-coding RNA Regulation to The Immune System
por: Wang, Jianjian, et al.
Publicado: (2023)

In situ antigen modification-based target-redirected universal chimeric antigen receptor T (TRUE CAR-T) cell therapy in solid tumors
por: Sun, Zhichen, et al.
Publicado: (2022)

RNA modification landscape of the human mitochondrial tRNA(Lys) regulates protein synthesis
por: Richter, Uwe, et al.
Publicado: (2018)

Molecular Basis of KAT2A Selecting Acyl-CoA Cofactors for Histone Modifications
por: Li, Sha, et al.
Publicado: (2023)

Modification of Cellular Membrane Functions by Pendolmycin
por: Umezawa, Kazuo, et al.
Publicado: (1989)

Structural modifications of the prostate in hypoxia, oxidative stress, and chronic ischemia
por: Thurmond, Portia, et al.
Publicado: (2015)

Role of circRNA in E3 Modification under Human Disease
por: Chen, Zishuo, et al.
Publicado: (2022)

SNP@lincTFBS: An Integrated Database of Polymorphisms in Human LincRNA Transcription Factor Binding Sites
por: Ning, Shangwei, et al.
Publicado: (2014)

In search of the mRNA modification landscape in plants
por: Chmielowska-Bąk, Jagna, et al.
Publicado: (2019)

Identification of the regulatory role of lncRNA HCG18 in myasthenia gravis by integrated bioinformatics and experimental analyses
por: Li, Shuang, et al.
Publicado: (2021)

Human transfer RNA modopathies: diseases caused by aberrations in transfer RNA modifications
por: Chujo, Takeshi, et al.
Publicado: (2021)

RNA 2′-O-Methylation (Nm) Modification in Human Diseases
por: Dimitrova, Dilyana G., et al.
Publicado: (2019)

RNA modification in cardiovascular disease: implications for therapeutic interventions
por: Wang, Cong, et al.
Publicado: (2023)

Editorial: RNA editing and modification in development and diseases
por: Li, Yanqiang, et al.
Publicado: (2022)

Competitive endogenous RNA network and pathway-based analysis of LncRNA single-nucleotide polymorphism in myasthenia gravis
por: Wang, Tianfeng, et al.
Publicado: (2021)

m(6)A regulator-mediated methylation modification patterns and tumor immune microenvironment characterization in endometrial cancer
por: Li, Kexin, et al.
Publicado: (2023)

Impact of tRNA Modifications and tRNA-Modifying Enzymes on Proteostasis and Human Disease
por: Pereira, Marisa, et al.
Publicado: (2018)

Overexpression of Human Telomerase RNA in Helicobacter pylori‐infected Human Gastric Mucosa
por: Hur, Kwon, et al.
Publicado: (2000)

The mitochondrial epitranscriptome: the roles of RNA modifications in mitochondrial translation and human disease
por: Bohnsack, Markus T., et al.
Publicado: (2017)

The RNA Modification N(6)-methyladenosine and Its Implications in Human Disease
por: Batista, Pedro J.
Publicado: (2017)

Modification of Interleukin-15 Serum Levels in Workers Exposed to Chemotherapeutic Agents
por: Spatari, Giovanna, et al.
Publicado: (2005)

The human tRNA taurine modification enzyme GTPBP3 is an active GTPase linked to mitochondrial diseases
por: Peng, Gui-Xin, et al.
Publicado: (2021)

Lnc2Cancer 3.0: an updated resource for experimentally supported lncRNA/circRNA cancer associations and web tools based on RNA-seq and scRNA-seq data
por: Gao, Yue, et al.
Publicado: (2020)

RNA modifications in aging-associated cardiovascular diseases
por: Yang, Xinyu, et al.
Publicado: (2022)

Editorial: Role of RNA Modification in Disease
por: Buratti, Emanuele, et al.
Publicado: (2019)

RNA Modification in Inflammatory Bowel Diseases
por: Nakayama, Mika, et al.
Publicado: (2022)

Modifications and functional genomics of human transfer RNA
por: Pan, Tao
Publicado: (2018)

Human Mitochondrial RNA Processing and Modifications: Overview
por: Jedynak-Slyvka, Marta, et al.
Publicado: (2021)

Expression of Human Telomerase RNA Is an Early Event of Stomach Carcinogenesis
por: Kuniyasu, Hiroki, et al.
Publicado: (1997)

RNA Modifications and RNA Metabolism in Neurological Disease Pathogenesis
por: Chatterjee, Biswanath, et al.
Publicado: (2021)

Integrated analysis of single-cell and bulk RNA sequencing data reveals immune-related lncRNA-mRNA prognostic signature in triple-negative breast cancer
por: Zhao, Hongying, et al.
Publicado: (2023)

N6-Methyladenosine RNA Modification Landscape in the Occurrence and Recurrence of Nasopharyngeal Carcinoma
por: Wang, Yu Min, et al.
Publicado: (2022)

Identifying and characterizing lincRNA genomic clusters reveals its cooperative functions in human cancer
por: Zhou, Hanxiao, et al.
Publicado: (2021)

Editorial: RNA Modification in Human Cancers: Roles and Therapeutic Implications
por: Zhou, You, et al.
Publicado: (2022)

CO(2)-sensitive tRNA modification associated with human mitochondrial disease
por: Lin, Huan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ja08tu7o2an4p2s12v17i0ms0b